Pulmonary Fibrosis Clinical Trials

• Pirfenidone for the Treatment of Patients with Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis (PF/IPF)
  ClinicalTrials.gov Identifier: NCT00080223 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis
  
• Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00063869 - Active, not recruiting
  Pulmonary Fibrosis
  
• Specimen Procurement from People with Hereditary Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00084305 - Recruiting
  Pulmonary Fibrosis
  
• Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00359736 - Recruiting
  Fibrosis, Pulmonary; Alveolitis, Fibrosing; Hypertension, Pulmonary; Exercise, Aerobic
  
• Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00517933 - Recruiting
  Pulmonary Fibrosis; Hypertension, Pulmonary
  
• Efficacy and Safety of Oral Bosentan in Patients with Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00071461 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• Minocycline Therapy for Lung Scarring in Patients With Idiopathic Pulmonary Fibrosis - a Pilot Study
  ClinicalTrials.gov Identifier: NCT00203697 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00287716 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• A Pilot Study of Aerosol Interferon-Gamma for Treatment of Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00563212 - Recruiting
  Pulmonary Fibrosis
  
• Inhaled Iloprost in Adults with Abnormal Pulmonary Pressure and Associated with Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00109681 - Completed
  Pulmonary Fibrosis; Pulmonary Hypertension
  
• Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00514683 - Recruiting
  Pulmonary Fibrosis
  
• Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00287729 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
  ClinicalTrials.gov Identifier: NCT00258570 - Recruiting
  Pulmonary Fibrosis
  
• Explanted Lung Tissues With Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00515567 - Recruiting
  Pulmonary Fibrosis
  
• The Influence of Personality on Pulmonary Fibrosis and Sarcoidosis
  ClinicalTrials.gov Identifier: NCT00504621 - Enrolling by invitation
  Sarcoidosis; Pulmonary Fibrosis
  
• Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00262405 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis
  
• Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide
  ClinicalTrials.gov Identifier: NCT00463983 - Recruiting
  Idiopathic Pulmonary Fibrosis
  
• Clinical Study With QAX576 in Patients With Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00532233 - Recruiting
  Idiopathic Pulmonary Fibrosis
  
• Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study
  ClinicalTrials.gov Identifier: NCT00131274 - Completed
  Idiopathic Pulmonary Fibrosis; Lung Disease; Pulmonary Fibrosis
  
• Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00439543 - Not yet recruiting
  Pulmonary Fibrosis; Pulmonary Hypertension
  
• Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00164138 - Active, not recruiting
  Cystic Fibrosis; Chronic Obstructive Pulmonary Disease (COPD)
  
• Phase I, Open-Label, Multi-Center, SIngle-Dose, Dose-Escalating, Safety, Tolerability and Pharmacokinetic Study of GC1008 in Patients with IPF
  ClinicalTrials.gov Identifier: NCT00125385 - Active, not recruiting
  Idiopathic Pulmonary Fibrosis; IPF
  
• Segmental Bronchoalveolar Lavage
  ClinicalTrials.gov Identifier: NCT00001618 - Recruiting
  Asthma; Pulmonary Fibrosis
  
• Azathioprine and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00518310 - Recruiting
  Idiopathic Pulmonary Fibrosis
  
• Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry
  ClinicalTrials.gov Identifier: NCT00540475 - Recruiting
  Idiopathic Pulmonary Fibrosis
  
• Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
  ClinicalTrials.gov Identifier: NCT00467831 - Recruiting
  Hermansky-Pudlak Syndrome (HPS); Pulmonary Fibrosis; Oculocutaneous Albinism; Platelet Storage Pool Deficiency; Metabolic Disease
  
• Effect of Lubiprostone on Nutritional Status and Pulmonary Function in Adults With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00577499 - Enrolling by invitation
  Cystic Fibrosis; Constipation; Nutrition
  
• Quantification of pulmonary neutrophil activity in cystic fibrosis using radiolabeled fluorodeoxyglucose and PET imaging
  ClinicalTrials.gov Identifier: NCT00023465 - Recruiting
  Cystic Fibrosis
  
• Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00352482 - Completed
  Pulmonary Fibrosis; Hypertension, Pulmonary
  
• Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
  ClinicalTrials.gov Identifier: NCT00212511 - Recruiting
  Idiopathic Pulmonary Fibrosis
  
• Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome
  ClinicalTrials.gov Identifier: NCT00001596 - Recruiting
  Albinism; Inborn Errors of Metabolism; Oculocutaneous Albinism; Platelet Storage Pool Deficiency; Pulmonary Fibrosis
  
• Specimen Collection for Individuals with Lung Disease Associated with Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00001884 - Recruiting
  Pulmonary Fibrosis; Rheumatoid Arthritis
  
• Lung Disease Associated with Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00001876 - Active, not recruiting
  Pulmonary Fibrosis; Rheumatoid Arthritis
  
• Identification of Genes Associated with Lung Disease in Patients with Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00001885 - Recruiting
  Healthy; Pulmonary Fibrosis; Rheumatoid Arthritis
  
• A Pilot Study of Aerosol Interferon-Gamma Treatment in Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00212563 - Completed
  Idiopathic Pulmonary Fibrosis
  
• A Study of the Safety and Clinical Effects of Interferon gamma-1b in Patients with Idiopathic Pulmonary Fibrosis (IPF)
  ClinicalTrials.gov Identifier: NCT00047658 - Completed
  Idiopathic Pulmonary Fibrosis
  
• Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
  ClinicalTrials.gov Identifier: NCT00366509 - Recruiting
  Pulmonary Disease; Oropharyngeal Disease; Lymphangioleiomyomatosis; Pulmonary Fibrosis; Asthma; Sarcoidosis
  
• A study of the safety and efficacy Interferon-gamma 1b in patients with Idiopathic Pulmonary Fibrosis (IPF)
  ClinicalTrials.gov Identifier: NCT00047645 - Completed
  Idiopathic Pulmonary Fibrosis
  
• An Open-label study of the safety and efficacy of subcutaneous recombinant interferon-gamma 1b (IFN-gamma 1b) in patients with Idiopathic Pulmonary Fibrosis (IPF)
  ClinicalTrials.gov Identifier: NCT00052052 - Completed
  Lung Disease; Pulmonary Fibrosis
  
• The INSPIRE Trial: A Study of Interferon gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)
  ClinicalTrials.gov Identifier: NCT00075998 - Terminated
  Idiopathic Pulmonary Fibrosis; Lung Disease; Pulmonary Fibrosis
  
• Safety and Tolerability Study of FG-3019 in Patients with Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00074698 - Completed
  Idiopathic Pulmonary Fibrosis
  
• Clinical and Basic Investigations into Hermansky-Pudlak Syndrome
  ClinicalTrials.gov Identifier: NCT00001456 - Recruiting
  Albinism; Intestinal Disease; Kidney Disease; Myocardial Disease; Pulmonary Fibrosis
  
• Efficacy and safety of oral bosentan in pulmonary fibrosis associated with scleroderma
  ClinicalTrials.gov Identifier: NCT00070590 - Completed
  Pulmonary Fibrosis; Scleroderma, Systemic
  
• An Open-Label Study of the Safety of Interferon gamma-1b in Patients with IPF
  ClinicalTrials.gov Identifier: NCT00076635 - Terminated
  Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis; Lung Disease
  
• QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00581997 - Not yet recruiting
  Pulmonary Fibrosis Secondary to Systemic Sclerosis
  
• Studying Patients with Cystic Fibrosis and Other Pulmonary and Pancreatic Disorders
  ClinicalTrials.gov Identifier: NCT00001223 - Recruiting
  Bronchiectasis; Cystic Fibrosis; Pancreatic Insufficiency
  
• Treatment of Idiopathic Pulmonary Fibrosis with Thalidomide
  ClinicalTrials.gov Identifier: NCT00162760 - Completed
  Idiopathic Pulmonary Fibrosis (IPF)
  
• Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00189176 - Completed
  Idiopathic Pulmonary Fibrosis
  
• Tissue Bank for Pulmonary Diseases
  ClinicalTrials.gov Identifier: NCT00546962 - Recruiting
  Cystic Fibrosis
  
• Mucin in Sputum of CF During Pulmonary Exacerbation
  ClinicalTrials.gov Identifier: NCT00202072 - Recruiting
  Cystic Fibrosis
  
• Microarray Analysis of Gene Expression in IPF
  ClinicalTrials.gov Identifier: NCT00258544 - Recruiting
  Pulmonary Fibrosis
  
• Can Quantitative Ultrasound Be Used for the Evaluation of Bone Health in Adolescents and Adults with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00221572 - Recruiting
  Cystic Fibrosis
  
• Study of Total Energy Expenditure in Infants and Children With Moderate to Severe Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00006273 - Active, not recruiting
  Cystic Fibrosis
  
• Assessment of Heart & Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation
  ClinicalTrials.gov Identifier: NCT00129350 - Recruiting
  Emphysema; Fibrosing Alveolitis; Cystic Fibrosis; End Stage Fibrotic Lung Disease; Bronchiectasis
  
• Genomic and Proteomic Analysis of Disease Progression in IPF
  ClinicalTrials.gov Identifier: NCT00373841 - Recruiting
  Pulmonary Fibrosis
  
• BUILD 3: Bosentan Use in Interstitial Lung Disease
  ClinicalTrials.gov Identifier: NCT00391443 - Recruiting
  Idiopathic Pulmonary Fibrosis
  
• Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy
  ClinicalTrials.gov Identifier: NCT00077064 - Active, not recruiting
  limited stage small cell lung cancer; Non-small cell lung cancer; Pulmonary Complications; Radiation Fibrosis
  
• Idiopathic Pulmonary Fibrosis: a Case-control Study
  ClinicalTrials.gov Identifier: NCT00005295 - Completed
  Lung Diseases; Pulmonary Fibrosis; Lung Diseases, Interstitial
  
• Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases
  ClinicalTrials.gov Identifier: NCT00005317 - Completed
  Lung Diseases; Pulmonary Fibrosis; Lung Diseases, Interstitial; Scleroderma, Systemic
  
• A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00079742 - Active, not recruiting
  Cystic Fibrosis
  
• Diffuse Fibrotic Lung Disease
  ClinicalTrials.gov Identifier: NCT00000596 - Completed
  Lung Diseases; Pulmonary Fibrosis; Sarcoidosis
  
• Linkage Study in Familial Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00016627 - Completed
  Pulmonary Fibrosis; Lung Diseases; Lung Diseases, Interstitial
  
• Herpesvirus in Idiopathic Pulmonary Fibrosis
  ClinicalTrials.gov Identifier: NCT00228670 - Recruiting
  Lung Diseases; Herpesvirus Infections
  
• Tissue Collection from People with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00015756 - Active, not recruiting
  Cystic Fibrosis
  
• Study of Hepatic Glucose Production and De novo Lipogenesis in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00014781 - Recruiting
  Cystic Fibrosis
  
• Evaluate the Effects of the Drug (SB-656933-AAA) on the Body After a Single Dose in Subjects Who Have Inhaled Ozone.
  ClinicalTrials.gov Identifier: NCT00551811 - Recruiting
  Chronic Obstructive Pulmonary Disease; Cystic Fibrosis
  
• Prevention of Disease Progress in Chronic Hepatitis C Patients with Liver Fibrosis
  ClinicalTrials.gov Identifier: NCT00049842 - Active, not recruiting
  Chronic Hepatitis C; Liver Fibrosis
  
• Behavioral & Nutritional Treatment to Help CF Preschoolers Grow
  ClinicalTrials.gov Identifier: NCT00241969 - Recruiting
  Cystic Fibrosis; Pancreatic Cystic Fibrosis
  
• Comparison of Inhaled Mannitol and rhDNase in Children with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00117208 - Active, not recruiting
  Cystic Fibrosis
  
• Phase I Pilot Study of Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer
  ClinicalTrials.gov Identifier: NCT00004471 - Active, not recruiting
  Cystic Fibrosis
  
• Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease
  ClinicalTrials.gov Identifier: NCT00357279 - Active, not recruiting
  Cystic Fibrosis
  
• Efficacy and Safety of 28 or 56 Days Treatment With Inhaled Tobramycin Nebuliser Solution for Pseudomonas Aeruginosa Infection in Children With Cystic Fibrosis.
  ClinicalTrials.gov Identifier: NCT00391976 - Active, not recruiting
  Cystic Fibrosis
  
• Growth Hormone Treatment Study in Children With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00256555 - Active, not recruiting
  Cystic Fibrosis
  
• Safety Study of Aztreonam Lysinate for Inhalation (AI) in Cystic Fibrosis Patients with P. Aeruginosa
  ClinicalTrials.gov Identifier: NCT00128492 - Active, not recruiting
  Cystic Fibrosis
  
• A Study of the Natural Progression of Interstitial Lung Disease (ILD)
  ClinicalTrials.gov Identifier: NCT00470327 - Recruiting
  Interstitial Lung Diseases; Idiopathic Pulmonary Fibrosis; Sarcoidosis
  
• Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00345774 - Active, not recruiting
  Pulmonary Hypertension; Chronic Obstructive Pulmonary Disease
  
• Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00205634 - Active, not recruiting
  Cystic Fibrosis
  
• Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00287430 - Active, not recruiting
  Cystic Fibrosis
  
• Metabolic Abnormalities in Hispanic Children With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00287443 - Active, not recruiting
  Cystic Fibrosis
  
• Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis
  ClinicalTrials.gov Identifier: NCT00440349 - Active, not recruiting
  Retroperitoneal Fibrosis
  
• Zinc Homeostasis and Kinetics in Children with Cystic Fibrosis (CF)
  ClinicalTrials.gov Identifier: NCT00104494 - Recruiting
  Cystic Fibrosis
  
• ARIES - Ambrisentan in Patients with Moderate to Severe Pulmonary Arterial Hypertension (PAH)
  ClinicalTrials.gov Identifier: NCT00091598 - Active, not recruiting
  Pulmonary Hypertension
  
• Fibrosis in Renal Allografts
  ClinicalTrials.gov Identifier: NCT00493194 - Recruiting
  Kidney Failure, Chronic; Transplantation; Immunosuppression; Interstitial Fibrosis
  
• Influence of DHA-Rich Supplement on DHA-Status and Health Evolution of Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00221546 - Active, not recruiting
  Cystic Fibrosis
  
• A Pilot Trial of Phenylbutyrate/Genistein Duotherapy (for Cystic Fibrosis)
  ClinicalTrials.gov Identifier: NCT00016744 - Recruiting
  Cystic Fibrosis
  
• Trental & Vitamin E for Radiation-Induced Fibrosis
  ClinicalTrials.gov Identifier: NCT00583700 - Recruiting
  Fibrosis
  
• Effectiveness of Pulmozyme in Infants With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00179998 - Active, not recruiting
  Cystic Fibrosis
  
• Safety and Efficacy of PTC124 for Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00237380 - Active, not recruiting
  Cystic Fibrosis
  
• Pharmacokinetic Study of Lansoprazole in Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00458614 - Active, not recruiting
  Cystic Fibrosis
  
• PHIRST-1: Safety and Efficacy of Tadalafil in the Treatment of Pulmonary Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00125918 - Active, not recruiting
  Pulmonary Hypertension
  
• Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients
  ClinicalTrials.gov Identifier: NCT00157690 - Active, not recruiting
  Cystic Fibrosis; Osteoporosis; Bone Diseases, Metabolic
  
• Gene Modifiers in Cystic Fibrosis Lung Disease
  ClinicalTrials.gov Identifier: NCT00037765 - Active, not recruiting
  Cystic Fibrosis; Lung Diseases
  
• Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis
  ClinicalTrials.gov Identifier: NCT00004489 - Recruiting
  Osteoporosis; Cystic Fibrosis
  
• Pulmonary Rehabilitation at Home Versus at the Gymnasium
  ClinicalTrials.gov Identifier: NCT00169897 - Active, not recruiting
  Chronic Obsctructive Pulmonary Disease
  
• Nasal Epithelial Cells/Blood Lymphocyte Markers for CF/CF Pulmonary Exacerbations
  ClinicalTrials.gov Identifier: NCT00381628 - Not yet recruiting
  Cystic Fibrosis
  
• Study of BSF 208075 evaluating exercise capacity in patients with pulmonary arterial hypertension
  ClinicalTrials.gov Identifier: NCT00046319 - Active, not recruiting
  Pulmonary Hypertension
  
• Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol with Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease
  ClinicalTrials.gov Identifier: NCT00004315 - Active, not recruiting
  Cystic Fibrosis; Gastrointestinal Diseases; Cholestasis
  
• Use of the Insulin Pump in Cystic Fibrosis Patients With Impaired Glucose Tolerance or CFRD and in Type 1 Diabetes Patients.
  ClinicalTrials.gov Identifier: NCT00287456 - Active, not recruiting
  Cystic Fibrosis Related Diabetes
  
• TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy
  ClinicalTrials.gov Identifier: NCT00293514 - Active, not recruiting
  Pulmonary Diseases; Intraoperative Complications
  
• Pulmonary Arteriopathy-Diagnostics and Therapy
  ClinicalTrials.gov Identifier: NCT00266175 - Active, not recruiting
  Pulmonary Stenosis